器官移植
器官移植
기관이식
OGRAN TRANSPLANTATION
2015年
1期
31-36
,共6页
李名安%黄明声%姜在波%钱结胜%李征然%张有用%庞鹏飞%单鸿
李名安%黃明聲%薑在波%錢結勝%李徵然%張有用%龐鵬飛%單鴻
리명안%황명성%강재파%전결성%리정연%장유용%방붕비%단홍
肝移植%缺血性胆道病变%经皮经肝胆管引流术%放射学,介入性
肝移植%缺血性膽道病變%經皮經肝膽管引流術%放射學,介入性
간이식%결혈성담도병변%경피경간담관인류술%방사학,개입성
Liver transplantation%Ischemic-type biliary lesion%Percutanous transhepatic biliary drainage%Radiology,interventional
目的:探讨肝移植术后缺血性胆道病变(ITBL)患者接受介入治疗的安全性及疗效。方法回顾性分析2006年1月至2014年2月在中山大学附属第三医院介入血管科接受介入治疗的76例肝移植术后ITBL患者的影像及临床资料。按胆道造影表现分为3组:肝门区狭窄组(28例),肝内多发狭窄组(42例),胆汁瘤组(6例)。治疗方式包括单纯经皮经肝胆管引流术(PTBD )、PTBD配合球囊扩张、PTBD配合球囊扩张及胆道内支架术。引流方式包括胆道外引流及胆道内外引流。术后随访并观察疗效及胆道并发症。结果76例患者的PTBD首次成功率为97%(74/76)。介入治疗的总体治愈率、好转率及无效率分别为21%(16/76)、51%(39/76)、28%(21/76)。其中,肝门区狭窄组治愈10例(36%),好转16例 (57%),无效2例 (7%),治疗有效22例 (93%);多发性狭窄组治愈6例 (14%),好转21例(50%),无效15例(36%),治疗有效27例(64%);胆汁瘤组好转2例 (2/6),无效4例(4/6)。肝门区狭窄患者的疗效优于多发性狭窄患者(P<0.05),多发性狭窄患者的疗效优于胆汁瘤患者(P<0.001)。引流管期间主要并发症为胆道感染,其中外引流及内外引流胆道感染发生率分别为20%(13/64)及67%(8/12),比较差异有统计学意义(P<0.001)。结论 PTBD是治疗肝移植术后ITBL的安全、有效手段之一。结合球囊扩张及内支架置入可有效改善患者症状,提高生存质量。采用胆道外引流可显著降低胆道感染发生率。
目的:探討肝移植術後缺血性膽道病變(ITBL)患者接受介入治療的安全性及療效。方法迴顧性分析2006年1月至2014年2月在中山大學附屬第三醫院介入血管科接受介入治療的76例肝移植術後ITBL患者的影像及臨床資料。按膽道造影錶現分為3組:肝門區狹窄組(28例),肝內多髮狹窄組(42例),膽汁瘤組(6例)。治療方式包括單純經皮經肝膽管引流術(PTBD )、PTBD配閤毬囊擴張、PTBD配閤毬囊擴張及膽道內支架術。引流方式包括膽道外引流及膽道內外引流。術後隨訪併觀察療效及膽道併髮癥。結果76例患者的PTBD首次成功率為97%(74/76)。介入治療的總體治愈率、好轉率及無效率分彆為21%(16/76)、51%(39/76)、28%(21/76)。其中,肝門區狹窄組治愈10例(36%),好轉16例 (57%),無效2例 (7%),治療有效22例 (93%);多髮性狹窄組治愈6例 (14%),好轉21例(50%),無效15例(36%),治療有效27例(64%);膽汁瘤組好轉2例 (2/6),無效4例(4/6)。肝門區狹窄患者的療效優于多髮性狹窄患者(P<0.05),多髮性狹窄患者的療效優于膽汁瘤患者(P<0.001)。引流管期間主要併髮癥為膽道感染,其中外引流及內外引流膽道感染髮生率分彆為20%(13/64)及67%(8/12),比較差異有統計學意義(P<0.001)。結論 PTBD是治療肝移植術後ITBL的安全、有效手段之一。結閤毬囊擴張及內支架置入可有效改善患者癥狀,提高生存質量。採用膽道外引流可顯著降低膽道感染髮生率。
목적:탐토간이식술후결혈성담도병변(ITBL)환자접수개입치료적안전성급료효。방법회고성분석2006년1월지2014년2월재중산대학부속제삼의원개입혈관과접수개입치료적76례간이식술후ITBL환자적영상급림상자료。안담도조영표현분위3조:간문구협착조(28례),간내다발협착조(42례),담즙류조(6례)。치료방식포괄단순경피경간담관인류술(PTBD )、PTBD배합구낭확장、PTBD배합구낭확장급담도내지가술。인류방식포괄담도외인류급담도내외인류。술후수방병관찰료효급담도병발증。결과76례환자적PTBD수차성공솔위97%(74/76)。개입치료적총체치유솔、호전솔급무효솔분별위21%(16/76)、51%(39/76)、28%(21/76)。기중,간문구협착조치유10례(36%),호전16례 (57%),무효2례 (7%),치료유효22례 (93%);다발성협착조치유6례 (14%),호전21례(50%),무효15례(36%),치료유효27례(64%);담즙류조호전2례 (2/6),무효4례(4/6)。간문구협착환자적료효우우다발성협착환자(P<0.05),다발성협착환자적료효우우담즙류환자(P<0.001)。인류관기간주요병발증위담도감염,기중외인류급내외인류담도감염발생솔분별위20%(13/64)급67%(8/12),비교차이유통계학의의(P<0.001)。결론 PTBD시치료간이식술후ITBL적안전、유효수단지일。결합구낭확장급내지가치입가유효개선환자증상,제고생존질량。채용담도외인류가현저강저담도감염발생솔。
Objective To investigate the safety and efficacy of interventional treatment for ischemic-type biliary lesion (ITBL)after liver transplantation (LT). Methods The clinical and imaging data of 76 patients with ITBL after LT,who received interventional treatment in the Department of Interventional Vascular Radiology of the Third Affiliated Hospital of Sun Yat-sen University from January 2006 to February 2014,were retrospectively analyzed. On the basis of the cholangiographic appearance,patients were classified into 3 groups:hilar biliary stricture group (n=28),multifocal biliary stricture group (n=42),and biloma group (n=6). The modalities of interventional treatment were percutanous transhepatic biliary drainage (PTBD), PTBD combined with balloon dilation,PTBD combined with balloon dilation and plastic stent implantation. The methods of biliary drainage included external drainage and external-internal drainage. All the patients were followed up after treatment. The curative effect and biliary complication was observed. Results The first successful rate of PTBD was 97% (74/76). The total curative rate,improvement rate and ineffective rate of interventional treatment were 21% (16/76),51% (39/76)and 28% (21/76). In hilar biliary stricture group,the cure,improvement and inefficacy rates were 36% (10/28),57% (16/28)and 7% (2/28).The efficacy rate was 93% (22/28 ). In multifocal biliary stricture group,the cure,improvement and inefficacy rates were 14% (6/42),50% (21/42)and 36% (15/42). The efficacy rate was 64% (27/42). In biloma group,2 cases (2/6)were cured and treatment of4 cases was ineffective. The efficacy ofhilar biliary stricture group was better than that of multifocal biliary stricture group (P<0.05 ). The efficacy of multifocal biliary stricture group was better than that of biloma group (P <0.001 ). The main biliary complication was biliary tract infection during drainage. The rates of bile tract infections were 20% (13/64) and 67% (8/12)in patients with external drainage and external-internal drainage,respectively. There was significant difference between these two items (P <0.001 ). Conclusions PTBD is a safe and effective therapeutic modality for ITBL after LT,which combined with balloon dilation and biliary stent implantation can improve patients’clinical symptoms,elevate patients’quality of life. The biliary external drainage can decrease the rate of biliary tract infection significantly.